期刊文献+

心血管疾病合并糖尿病患者的循证药物治疗 被引量:3

Evidence-based Pharmaceutical Treatment for Patients with Coronary Artery Disease Complicating with Diabetes Mellitus
原文传递
导出
摘要 目的:为心血管疾病合并糖尿病患者制订合理的药物治疗方案。方法:根据1例患者临床状况提出2个问题,通过计算机检索MEDLINE(1975年-2011年3月)、Cochrane Central Register of Controlled Trial(s2011年第1期)、Cochrane图书馆(2011年第1期),根据所获证据为患者制订药物治疗方案。结果:最终纳入3篇系统评价,14篇随机对照试验。现有证据显示:心血管疾病合并糖尿病患者的药物治疗应在避免低血糖发生的前提下使用胰岛素,并且最好使用速效人胰岛素类似物。结论:以循证医学的方法,为心血管疾病合并糖尿病患者选择合理的药物治疗方案,可降低病死率,减少不良反应的发生。 OBJECTIVE:To develop rational drug treatment plan for patients with coronary artery disease complicating with diabetes mellitus.METHODS:Two problems were put forward according to the health state of one patient.We searched MEDLINE(1975-Mar.2011),Cochrane Central Register of Controlled Trials(No.1,2011) and Cochrane library(No.1,2011).The drug treatment plan was made according to obtained evidence.RESULTS:3 systematic reviews and 14 RCTs were involved finally.The evidence indicated that the treatment plan of patients with coronary artery disease and diabetes mellitus should be given insulin treatment with avoiding hypoglycemia,and quick effective human insulin analog was the best.CONCLUSION:Based on evidence-based medicine,the treatment plan for patients with coronary artery disease complicating with diabetes mellitus is selected,and it reduces mortality and decreases the occurrence of adverse drug reactions.
出处 《中国药房》 CAS CSCD 2012年第14期1330-1333,共4页 China Pharmacy
关键词 心血管疾病 糖尿病 循证药物治疗 Coronary artery disease Diabetes mellitus Evidence-based pharmaceutical treatment
  • 相关文献

参考文献16

  • 1Ryden L,Standl E,Bartnik M,et al.Guidelines on diabe-tes,pre-diabetes,and cardiovascular diseases:executive summary[J].Eur Heart J,2007,28(1):88.
  • 2中国心脏调查组,胡大一,潘长玉.中国住院冠心病患者糖代谢异常研究——中国心脏调查[J].中华内分泌代谢杂志,2006,22(1):7-10. 被引量:470
  • 3American Diabetes Association.Standards of medical care in diabetes-2011[J].Diabetes Care,2011,34(1):S11.
  • 4陈灏珠.实用内科学[M].北京:人民卫生出版社,2009.
  • 5Henderson JN.Hypoglycaemia in insulin-treated Type2di-abetes:frequency,symptoms and impaired awareness[J].Diabet Med,2003,20(12):1016.
  • 6Siebenhofer A.Short acting insulin analogues versus regu-lar human insulin in patients with diabetes mellitus[J].Co-chrane Database Syst Rev,2006,(2):3287.
  • 7Klepzig H.Sulfonylureas and ischaemic preconditioning A double-blind,placebo-controlled evaluation of glimepiri-de and glibenclamide[J].European Heart Journal,1999,20(6):439.
  • 8Steven E.Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes[J].The New England Journal of Medicine,2007,356(24):2457.
  • 9Philip DH.Rosiglitazone evaluated for cardiovascular out-comes in oralagent combination therapy for type2diabe-tes(RECORD):a multicentre,randomised,open-label trial[J].Lancet,2009,373(20):2125.
  • 10Dormandy J.Secondary prevention of macrovascular eve-nts in patients with type2diabetes in the PROactive Study(PROspective pioglitAzone Clinical Trial In macro-Vascular Events):a randomised controlled trial[J].Lan-cet,2005,366(20):1279.

二级参考文献29

  • 1张石革,陈瑞红.胰岛素类似物的进展与优势[J].中国医药导刊,2005,7(4):289-292. 被引量:8
  • 2李素青,田玉华,朱敏,杨超元.中老年糖尿病流行病学调查方法探讨[J].实用老年医学,1996,10(4):175-176. 被引量:13
  • 3King H,Aubert RE,Herman WH.Global burden of diabetes 1995-2025.Prevalence,numerical estimates and projections.Diabetes Care,1998,21:1414-1431.
  • 4Bartnik M,Malmberg K,Hamsten A,et al.Abnormal glucose tolerance-a common risk factor in patients with acute myocardial infarction in comparison with population-based controls.J Int Med,2004,256:288-297.
  • 5Coutinho M,Gerstein HC,Wang Y,et al.The relationship between glucose and incident cardiovascular events:a metaregression analysis of published data from 20 studies of 95 783 individuals followed for 12.4years.Diabetes Care,1999,22:233-240.
  • 6The DECODE study group on behalf of the European Diabetes Epidemiology Group.Glucose tolerance and cardiovascular mortality.Arch Int Med,2001,161:397-404.
  • 7Bartnik M,Malmberg K,Norhammar A,et al.Newly detected abnormal glucose tolerance:an important predictor of long-term outcome after myocardial infarction.Eur Heart J,2004,25:1990-1997.
  • 8Norhammar A,Tenerz A,Nilsson G,et al.Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus:a prospective study.Lancet,2002,359:2140-2144.
  • 9Bartnik M,Ryden L,Ferrari R,et al.The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe:the Euro Heart Survey on diabetes and the heart.Eur Heart J,2004,25:1880-1890.
  • 10Hashimoto K,Ikewaki K,Yagi H,et al.Glucose intolerance is common in Japanese patients with acute coronary syndrome who were not previously diagnosed with diabetes.Diabetes Care,2005,28:1182-1186.

共引文献1084

同被引文献18

  • 1陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2010:282.
  • 2Vinik A1, Maser RE, Mitchell BD, et al. Diabetic autonomic neurop- athy[ J]. Diabetes Care,2003,26(5) :1553 - 1579.
  • 3Song Y,Wang L,Pittas AG.et al. Blood 2 5-Hydroxy Vi-tamin D Levels and Incident Type 2 Diabetes[J]. DiabetesCare,2013,36(5):1 422.
  • 4Cigolini M, Iagulli MP.Serum 25-hydroxyvitamin D3 con-centrations and prevalence of cardiovascular diseaseamong type 2 diabetic patients [J]. Diabetes Care, 2006,29(3):722.
  • 5Zhao G, Huang L, Song M. Baseline serum uric acid lev-el as a predictor of cardiovascular disease related mortali-ty and all-cause mortality : a meta-analysis of prospectivestudies [J]. Atherosclerosis,2013,231:61.
  • 6Bonak daran S, Varasteh AR. Correlation between serum25 hydroxy vitamin D3 and laboratory risk markers of car-diocascular disease in type 2 diabetic patients[J]. Saudi2009,30(4) :509.
  • 7黄佳佳,凌丹芸,汤正义,王卫庆,李小英,宁光.糖尿病心脏自主神经病变程度与心肌缺血发生和严重性的关系[J].内科理论与实践,2008,3(5):343-346. 被引量:9
  • 8项磊,刘菊妍.金元四大家论治消渴思想探析[J].江苏中医药,2009,41(8):7-8. 被引量:6
  • 9中国心血管病预防指南[J].中华心血管病杂志,2011,39(1):3-22. 被引量:639
  • 10孙文丽,施英.老年人猝死临床分析及治疗策略[J].浙江中西医结合杂志,2011,21(4):242-244. 被引量:3

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部